Sign in

CIK 0001178253

  • Non-accelerated filer
  • Smaller reporting company

SCYNEXIS INC

Sign in to watch
Ticker
SCYX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
562181648
Phone
+1 201-884-5485
Business address
1 EVERTRUST PLAZA, 13TH FLOOR, JERSEY CITY, NJ, 07302-6548
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market sale 10% owner sold 599,000 shares at an average $7.86 ($4,705,431)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market buy Director bought 8,000 shares at $6.25 ($50,000)
  8. 4 Open-market buy Chief Executive Officer bought 40,000 shares at $6.25 ($250,000)
  9. 4 Open-market buy General Counsel bought 1,600 shares at $6.25 ($10,000)
  10. 4 Open-market buy Director bought 8,000 shares at $6.25 ($50,000)
  11. 4 Open-market buy Director bought 3,200 shares at $6.25 ($20,000)
  12. 4 Open-market buy Director bought 4,000 shares at $6.25 ($25,000)
  13. 4 Open-market buy Chief Financial Officer bought 600 shares at $6.25 ($3,750)
  14. 4 Open-market buy Director bought 5,000 shares at $6.25 ($31,250)
  15. 4 Open-market buy Chief Medical Officer bought 1,600 shares at $6.25 ($10,000)
  16. 4 Shares withheld for taxes General Counsel gave up 3,396 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Financial Officer gave up 4,459 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Medical Officer gave up 5,498 shares (to pay taxes)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 5 of 16 · 314 filings